Teva and Biolojic Design Ink Exclusive License for Atopic Dermatitis and Asthma Antibody Therapy

Biolojic’s BD9 is a multibody that was computationally designed as a multi specific antibody targeting IL-13 / TSLP to treat inflammatory diseases....

December 15, 2023 | Friday | News
Microbot Medical and Corewell Health Collaborate on LIBERTY® Robotic Surgical System for Telerobotic Procedures

Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System,announced it has entered into a collabo...

December 15, 2023 | Friday | News
Freya Biosciences Raises $38M in Significant Series A for Women’s Reproductive Immunotherapies

Series A led by Sofinnova Partners and OMX Ventures Freya Biosciences, a trans-Atlantic biotech company specializing in women's health, announced today a ...

December 12, 2023 | Tuesday | News
Sanofi's Pipeline Transformation for Immunology Leadership Through Record Potential Blockbusters

Details strong pipeline including Sanofi’s record 12 blockbuster opportunities under clinical evaluation: 9 innovative medicines and vaccines with ...

December 07, 2023 | Thursday | News
Novartis' Fabhalta® (iptacopan) gains FDA approval as the first oral monotherapy for adults with PNH, showing superior hemoglobin improvement without transfusions.

Approval based on APPLY-PNH trial in adults with PNH and anemia despite prior anti-C5 treatment, and supported by the APPOINT-PNH study in complement inh...

December 06, 2023 | Wednesday | News
Pfizer Reveals Positive Phase 2b Results for Obesity Drug Danuglipron

Danuglipron demonstrated mean placebo-adjusted weight reductions ranging from -8% to -13% at 32 weeks and -5% to -9.5% at 26 weeks While most common adv...

December 04, 2023 | Monday | News
ReWalk Robotics Showcases AI in Exoskeleton Prototype

ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in r...

November 28, 2023 | Tuesday | News
iCAD and GE Healthcare Collaborate to Boost Breast Cancer Detection with AI Solutions

Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite* AI applications streamline workflow and s...

November 28, 2023 | Tuesday | News
Evaxion Reveals Innovative AI-Immunology™ Cancer Vaccine Concept

Proof of Concept – Evaxion’s AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological cance...

November 28, 2023 | Tuesday | News
Spineway Expands Global Reach with VEOS Implant Rollout in Spain, Colombia, and Indonesia

Successful First Implants in Spain, Accelerating Market Penetration New Approvals in Colombia and Indonesia Boost Sales Prospects Spineway Advances as ...

November 27, 2023 | Monday | News
SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder

SciSparc’s novel SCI-210 therapy is not only a medication based on CBD; it is also a unique combination of cannabidiol (CBD) and SciSparc's proprieta...

November 27, 2023 | Monday | News
Mesoblast Seeks Orphan Drug Status for Rexlemestrocel-L in Treating Severe Congenital Heart Disease

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that it has filed for orphan ...

November 27, 2023 | Monday | News
Surge in Respiratory Illness Overwhelms Chinese Hospitals, WHO Requests Data

A wave of respiratory illnesses, accompanied by alarming clusters of pneumonia cases, has inundated hospitals in northern China, sparking deep concerns abo...

November 25, 2023 | Saturday | News
STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolio

Partnership agreement signed on 22 November to broaden distribution and promotion of cough and cold brands such as Shidagong, Gelite and Ruike in China&n...

November 24, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close